Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0· v2Sign in
← Cases

IRAK4

RBC: IRAK4 · Substrate: MBP · medium confidenceReferenceDerived

Top inhibitors

MeasuredDerived
DrugInhibition %Gini
Vandetanib86.90.72
Gilteritinib86.30.51
Pacritinib82.80.45
Sunitinib80.80.52
Brigatinib76.20.51
Tepotinib72.70.73
Bosutinib66.40.55
Alectinib58.10.65
Defactinib45.70.45
Midostaurin45.50.50
Gefitinib42.70.65
Canertinib33.80.67
Dacomitinib31.80.66
Pexidartinib30.20.63
Ponatinib25.90.53

Known variants

No variants catalogued.
Open in new tab